Jaehde U - Search Results

1

Identification of potentially causative drugs associated with hypotension: A scoping review.

Sari N, Jaehde U, Wermund AM. Sari N, et al. Among authors: jaehde u. Arch Pharm (Weinheim). 2025 Jan;358(1):e2400564. doi: 10.1002/ardp.202400564. Epub 2024 Nov 28. Arch Pharm (Weinheim). 2025. PMID: 39607387 Free PMC article.

2

Machine Learning Methods for Precision Dosing in Anticancer Drug Therapy: A Scoping Review.

Teplytska O, Ernst M, Koltermann LM, Valderrama D, Trunz E, Vaisband M, Hasenauer J, Fröhlich H, Jaehde U. Teplytska O, et al. Among authors: jaehde u. Clin Pharmacokinet. 2024 Sep;63(9):1221-1237. doi: 10.1007/s40262-024-01409-9. Epub 2024 Aug 17. Clin Pharmacokinet. 2024. PMID: 39153056 Free PMC article. Review.

3

Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin.

Mohn C, Häcker HG, Hilger RA, Gütschow M, Jaehde U. Mohn C, et al. Among authors: jaehde u. Pharmazie. 2013 Jul;68(7):622-7. Pharmazie. 2013. PMID: 23923647

4

Prioritisation of Adverse Drug Events Leading to Hospital Admission and Occurring during Hospitalisation: A RAND Survey.

Haerdtlein A, Boehmer AM, Karsten Dafonte K, Rottenkolber M, Jaehde U, Dreischulte T. Haerdtlein A, et al. Among authors: jaehde u. J Clin Med. 2022 Jul 22;11(15):4254. doi: 10.3390/jcm11154254. J Clin Med. 2022. PMID: 35893345 Free PMC article.

5

Vucur C, Wirtz DA, Weinhold L, Zipfel M, Schmid M, Schmidt-Wolf IG, Jaehde U. Vucur C, et al. Among authors: jaehde u. J Oncol Pharm Pract. 2021 Sep;27(6):1439-1446. doi: 10.1177/1078155220962178. Epub 2020 Oct 6. J Oncol Pharm Pract. 2021. PMID: 33019873 Clinical Trial.

6

Therapeutic drug monitoring of oral targeted antineoplastic drugs.

Mueller-Schoell A, Groenland SL, Scherf-Clavel O, van Dyk M, Huisinga W, Michelet R, Jaehde U, Steeghs N, Huitema ADR, Kloft C. Mueller-Schoell A, et al. Among authors: jaehde u. Eur J Clin Pharmacol. 2021 Apr;77(4):441-464. doi: 10.1007/s00228-020-03014-8. Epub 2020 Nov 9. Eur J Clin Pharmacol. 2021. PMID: 33165648 Free PMC article. Review.

7

Minimising treatment-associated risks in systemic cancer therapy.

Jaehde U, Liekweg A, Simons S, Westfeld M. Jaehde U, et al. Pharm World Sci. 2008 Apr;30(2):161-8. doi: 10.1007/s11096-007-9157-4. Epub 2007 Sep 29. Pharm World Sci. 2008. PMID: 17906939 Free PMC article. Review.

8

Pharmaceutical care for patients with breast and ovarian cancer.

Liekweg A, Westfeld M, Braun M, Zivanovic O, Schink T, Kuhn W, Jaehde U. Liekweg A, et al. Among authors: jaehde u. Support Care Cancer. 2012 Nov;20(11):2669-77. doi: 10.1007/s00520-012-1385-z. Support Care Cancer. 2012. PMID: 22298194 Free PMC article.

9

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.

Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, Jaehde U. Schlender JF, et al. Among authors: jaehde u. Clin Pharmacokinet. 2016 Dec;55(12):1573-1589. doi: 10.1007/s40262-016-0422-3. Clin Pharmacokinet. 2016. PMID: 27351180 Free PMC article.

10

Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).

Hagelstein V, Ortland I, Wilmer A, Mitchell SA, Jaehde U. Hagelstein V, et al. Among authors: jaehde u. Ann Oncol. 2016 Dec;27(12):2294-2299. doi: 10.1093/annonc/mdw422. Epub 2016 Sep 28. Ann Oncol. 2016. PMID: 27681863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters